Sun Pharma reports 16% rise in Q3 consolidated net profit

01 Feb 2026 Evaluate

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2025 (Q3FY26).

The company has reported 38.97% fall in its net profit at Rs 705.44 crore for the third quarter ended December 31, 2025 as compared to Rs 1,155.80 crore for the same quarter in the previous year. The total income of the company decreased by 6.11% at Rs 5,867.67 crore for Q3FY26 as compared to Rs 6,249.83 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 16.03% rise in its net profit at Rs 3,368.81 crore for the third quarter ended December 31, 2025 as compared to Rs 2,903.38 crore for the same quarter in the previous year. The total income of the company increased by 13.85% at Rs 16,099.38 crore for Q3FY26 as compared to Rs 14,141.08 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1717.40 17.65 (1.04%)
17-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.40
Dr. Reddys Lab 1285.00
Cipla 1343.35
Zydus Lifesciences 906.75
Lupin 2247.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×